Drug name - Atelvia

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8246989 APIL Dosage forms of bisphosphonates Jan, 2026

(3 years from now)

US7645459 APIL Dosage forms of bisphosphonates Jan, 2028

(5 years from now)

US7645460 APIL Dosage forms of risedronate Jan, 2028

(5 years from now)

Drugs and Companies using RISEDRONATE SODIUM ingredient

Treatment: Treatment of osteoporosis in postmenopausal women

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
35MG TABLET, DELAYED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.